Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular tranexamic acid added to morphine and ketorolac after ACL reconstruction
IRCT20221230056983N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid, morphine, ketorolac and lidocaine in anterior cruciate ligament injury (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Postoperative pain reduction, Patient satisfaction and 1 more. Started Apr 2022; status: completed.
02
Drugs
tranexamic acidmorphineketorolaclidocaine
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on IRCT20221230056983N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221230056983N1.